EUVIMEDEUVIMED entdecken
Crossref

EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States

Weiming (Ariel) Dong, Mark Bounthavong

Value in Health · 2025-07 · 28 (6) · S138

DOI: 10.1016/j.jval.2025.04.2014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2025-07. Verfasst von Weiming (Ariel) Dong und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dong, W. A., & Bounthavong, M. (2025). EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States. Value in Health, 28(6), S138. https://doi.org/10.1016/j.jval.2025.04.2014

Vancouver

Dong WA, Bounthavong M. EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States. Value in Health. 2025;28(6):S138. doi:10.1016/j.jval.2025.04.2014

BibTeX
@article{Dong2025,
  author = {Dong, Weiming (Ariel) and Bounthavong, Mark},
  title = {EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States},
  journal = {Value in Health},
  year = {2025},
  volume = {28},
  number = {6},
  pages = {S138},
  doi = {10.1016/j.jval.2025.04.2014}
}
Kostenlos starten →